When did TANDEM DIABETES CARE INC (TNDM) report earnings last quarter?
TANDEM DIABETES CARE INC (TNDM) last reported earnings on 2/19/2026.
NASDAQ:TNDM • US8753722037
Past quarterly earnings results for TANDEM DIABETES CARE INC (TNDM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.01 | -0.08 | 88.09% | -200.00% | 290.383M | 282.57M | 2.76% | 2.74% |
| Q3 2025 | -0.31 | -0.32 | 3.18% | 11.43% | 249.253M | 241.7M | 3.12% | 2.17% |
| Q2 2025 | -0.48 | -0.41 | -18.66% | -0.83% | 240.678M | 243.35M | -1.10% | 8.46% |
| Q1 2025 | -0.66 | -0.62 | -5.69% | -4.76% | 234.422M | 224.6M | 4.37% | 21.58% |
| Q4 2024 | 0.01 | -0.23 | 104.27% | 103.70% | 282.648M | 257.02M | 9.97% | 43.62% |
| Q3 2024 | -0.35 | -0.41 | 15.37% | 7.89% | 243.971M | 228.14M | 6.94% | 31.43% |
| Q2 2024 | -0.48 | -0.56 | 13.62% | 12.73% | 221.91M | 209.01M | 6.17% | 11.95% |
| Q1 2024 | -0.63 | -0.77 | 18.48% | 67.19% | 192.82M | 177.11M | 8.87% | 13.84% |
| Q4 2023 | -0.27 | -0.26 | -3.93% | -8.00% | 196.796M | 206.81M | -4.84% | -10.75% |
| Q3 2023 | -0.38 | -0.34 | -10.81% | -40.74% | 185.622M | 196.56M | -5.56% | -9.23% |
| Q2 2023 | -0.55 | -0.54 | -1.38% | -129.17% | 198.23M | 201.31M | -1.53% | -1.03% |
| Q1 2023 | -1.92 | -0.53 | -264.32% | -734.78% | 169.383M | 173.63M | -2.45% | -3.70% |
| Q4 2022 | -0.25 | -0.06 | -330.60% | -256.25% | 220.5M | 226.26M | -2.55% | 5.00% |
| Q3 2022 | -0.27 | -0.05 | -444.44% | -400.00% | 204.5M | 211.86M | -3.47% | 13.86% |
| Q2 2022 | -0.24 | 0.03 | -835.29% | -500.00% | 200.3M | 209.31M | -4.30% | 16.39% |
| Q1 2022 | -0.23 | -0.06 | -288.24% | -187.50% | 175.9M | 171.58M | 2.52% | 24.75% |
| Q4 2021 | 0.16 | 0.22 | -26.86% | -27.27% | 210M | 202.66M | 3.62% | 24.93% |
| Q3 2021 | 0.09 | 0.06 | 52.31% | 160.00% | 179.6M | 174.84M | 2.72% | 45.31% |
| Q2 2021 | 0.06 | -0.08 | 170.93% | 113.33% | 172.1M | 146.23M | 17.69% | 57.60% |
| Q1 2021 | -0.08 | -0.16 | 50.85% | 68.00% | 141M | 124.4M | 13.34% | 44.02% |
| Q4 2020 | 0.22 | 0.12 | 80.17% | - | 168.1M | 144.41M | 16.40% | - |
| Q3 2020 | -0.15 | -0.11 | -40.50% | - | 123.6M | 117.46M | 5.23% | - |
| Q2 2020 | -0.45 | -0.24 | -84.05% | - | 109.2M | 88.893M | 22.84% | - |
| Q1 2020 | -0.25 | -0.17 | -43.27% | - | 97.9M | 86.148M | 13.64% | - |
Notes
TANDEM DIABETES CARE INC (TNDM) last reported earnings on 2/19/2026.
TANDEM DIABETES CARE INC (TNDM) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, TANDEM DIABETES CARE INC (TNDM) has beaten EPS estimates in 2 out of 4 releases.